Diligence memo · auto-generated · as of July 2, 2026
Rediscovery Life Sciences AKI LLC
Rediscovery Life Sciences AKI LLC looks under-valued against its niche peers and is at-risk on financing cadence.
Businessfiled
Rediscovery Life Sciences AKI LLC operates in Other Health Care, based in CHARLESTON.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Rediscovery Life Sciences AKI LLC has raised $5.0M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $3.8M on 2020-04-22.
Most recent recorded round closed around 2023-03-27.
Valuation (modeled)modeled
Provath models Rediscovery Life Sciences AKI LLC at approximately $3.4M (range $381K–$13M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.29× the median modeled value of Seed Other Health Care companies in 2022–2024 (244 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 40 months.
Last raise 3.3 yr ago; this sector typically re-raises about every 14 months.
Past due for a raise versus sector cadence — watch for distress or a bridge.
The last round was 8.4× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 63% of Other Health Care peers (5377 compared).
Modeled value ranks above 15% of those peers.
Closest niche peers: Elmntri LLC, Atreo, Inc., descendantsDNA, Inc., Westover Project Investor LLC, Dentulu Inc.
Peoplefiled
8 named people on file across officers, directors and signatories.
Risks & flagsmixed
Overdue for a raise versus sector norm — distress or bridge risk.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.